Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from Singapore
Import trade data for Indian businesses
🇸🇬 Singapore — Country Profile
Capital
Singapore
GDP (USD)
$397.00
Population
5.9M
Currency
Singapore Dollar
Trade Agreement
India-ASEAN FTA
Import Snapshot
India imported $3.3M of antisera and other blood fractions and modified immunological products, whether or not obtained by m from Singapore in 2023 — -62.9% YoY.
Based on HS Code 3002 import data (UN Comtrade)
Import History — Singapore to India
2023
$3.3M
HS 3002 imports
2022
$8.8M
HS 3002 imports
About Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M Imports from Singapore
Singapore is one of the supplying countries for antisera and other blood fractions and modified immunological products, whether or not obtained by m to the Indian market, classified under HS heading 3002. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.
Other Countries Supplying Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M to India
Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from Singapore
Get expert guidance on sourcing, customs procedures, and compliance.
Contact XIMPEX